Research and Markets: Tardive Dyskinesia-Pipeline Insights - Reviewing Key Players Involved in the Therapeutics Development for Tardive Dyskinesia

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/6d56t6/tardive) has announced the addition of the "Tardive Dyskinesia-Pipeline Insights" report to their offering.

Tardive Dyskinesia- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Tardive Dyskinesia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Tardive Dyskinesia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Tardive Dyskinesia- Pipeline Insights Report covers the Tardive Dyskinesia pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Tardive Dyskinesia related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Tardive Dyskinesia.

Scope

  • The report provides a Tardive Dyskinesia Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Tardive Dyskinesia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Tardive Dyskinesia and also provide company profiling

Key Topics Covered:

  • Tardive Dyskinesia Overview
  • Tardive Dyskinesia Pipeline Therapeutics
  • Tardive Dyskinesia Therapeutics under Development by Companies
  • Tardive Dyskinesia Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Tardive Dyskinesia Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Tardive Dyskinesia Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Tardive Dyskinesia Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Tardive Dyskinesia - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Tardive Dyskinesia - Discontinued Products
  • Tardive Dyskinesia - Dormant Products
  • Companies Involved in Therapeutics Development for Tardive Dyskinesia

For more information visit http://www.researchandmarkets.com/research/6d56t6/tardive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals